Cellular Therapy of Cancer Symposium

This meeting is organized by the ATTACK research consortium, a large European research project covering 17 Centres. The focus is on genetically engineering T cells to target malignant disease. The 2010 symposium will cover a multifaceted range of basic science, preclinical and clinical aspects including, but not limited to, T cell homeostasis and differentiation, tumor environment, cytokines, immune responsiveness, gene transfer and cell production.